OPR - Delayed Quote USD

LYRA Jul 2024 7.500 call (LYRA240719C00007500)

0.7000

0.0000

(0.00%)

At close: April 19 at 11:39 AM EDT

Key Events

Loading Chart for LYRA240719C00007500

9/21 12:03 PM

DELL

Previous Close 0.7000
Open 0.7000
Bid 0.4000
Ask 0.8500
Strike 7.50
Expire Date 2024-07-19
Day's Range 0.7000 - 0.7000
Contract Range --
Volume 8
Open Interest 3.06k

Lyra Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Lyra Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Lyra Therapeutics (LYRA) Soars 6.5%: Is Further Upside Left in the Stock?

Lyra Therapeutics (LYRA) Soars 6.5%: Is Further Upside Left in the Stock?

Private equity firms who hold 39% of Lyra Therapeutics, Inc. (NASDAQ:LYRA) gained 6.8%, institutions profited as well

Private equity firms who hold 39% of Lyra Therapeutics, Inc. (NASDAQ:LYRA) gained 6.8%, institutions profited as well

Lyra Therapeutics (LYRA) Is a Great Choice for 'Trend' Investors, Here's Why

Lyra Therapeutics (LYRA) Is a Great Choice for 'Trend' Investors, Here's Why

Lyra Therapeutics Inc (LYRA) Posts Year-End Financial Results, Aligns with EPS Projections

Wall Street Analysts See a 101.81% Upside in Lyra Therapeutics (LYRA): Can the Stock Really Move This High?

Wall Street Analysts See a 101.81% Upside in Lyra Therapeutics (LYRA): Can the Stock Really Move This High?

Lyra Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

Lyra Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

Here's Why Momentum in Lyra Therapeutics, Inc. (LYRA) Should Keep going

Here's Why Momentum in Lyra Therapeutics, Inc. (LYRA) Should Keep going

Lyra Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Lyra Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Zacks Industry Outlook Highlights United Therapeutics, Esperion Therapeutics., Heron Therapeutics, Lyra Therapeutics and Aldeyra Therapeutics

Zacks Industry Outlook Highlights United Therapeutics, Esperion Therapeutics., Heron Therapeutics, Lyra Therapeutics and Aldeyra Therapeutics

5 Small Drug Stocks to Buy From a Rebounding Industry

5 Small Drug Stocks to Buy From a Rebounding Industry

Strength Seen in Lyra Therapeutics, Inc. (LYRA): Can Its 6.9% Jump Turn into More Strength?

Strength Seen in Lyra Therapeutics, Inc. (LYRA): Can Its 6.9% Jump Turn into More Strength?